The diffusion of generics after patent expiry in Germany
- 16 November 2015
- journal article
- Published by Springer Nature in The European Journal of Health Economics
- Vol. 17 (8) , 1027-1040
Abstract
To identify the influences on the diffusion of generics after patent expiry, we analyzed 65 generic entries using prescription data of a large German sickness fund between 2007 and 2012 in a sales model. According to theory, several elements are responsible for technology diffusion: (1) time reflecting the rate of adaption within the social system, (2) communication channels, and (3) the degree of incremental innovation, e.g., the modifications of existing active ingredient’s strength. We investigated diffusion in two ways: (1) generic market share (percentage of generic prescriptions of all prescriptions of a substance) and, (2) generic sales quantity (number of units sold) over time. We specified mixed regression models. Generic diffusion takes considerable time. An average generic market share of about 75 % was achieved not until 48 months. There was a positive effect of time since generic entry on generic market share (p < 0.001) and sales (p < 0.001). Variables describing the communication channels and the degree of innovation influenced generic market share (mostly p < 0.001), but not generic sales quantity. Market structure, e.g., the number of generic manufacturers (p < 0.001) and prices influenced both generic market share and sales. Imperfections in generic uptake through informational cascades seem to be largely present. Third-party payers could enhance means to promote generic diffusion to amplify savings through generic entry.Keywords
Funding Information
- Federal Ministry of Education and Research in Germany (BMBF 01EH1101A)
This publication has 59 references indexed in Scilit:
- A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case studyBMC Pharmacology and Toxicology, 2013
- Longitudinal beta regression models for analyzing health-related quality of life scores over timeBMC Medical Research Methodology, 2012
- Analyzing generic and branded substitution patterns in the Netherlands using prescription dataBMC Health Services Research, 2011
- Determinants of generic drug substitution in SwitzerlandBMC Health Services Research, 2011
- State Generic Substitution Laws Can Lower Drug Outlays Under MedicaidHealth Affairs, 2010
- Innovation diffusion and new product growth models: A critical review and research directionsInternational Journal of Research in Marketing, 2010
- Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent moleculesInternational Journal of Research in Marketing, 2008
- Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular DiseaseJAMA, 2008
- Competition in off-patent drug markets: Issues, regulation and evidenceEconomic Policy, 2008
- Strategic Supply Chain Optimization for the Pharmaceutical IndustriesIndustrial & Engineering Chemistry Research, 2000